“BioTime Licenses Beckman Research Institute of City of Hope to Manufacture Clinical Grade Stem Cells ALAMEDA, Calif.--(BUSINESS WIRE)--Apr. 22, 2015-- BioTime, Inc. (NYSE MKT: BTX) today announced a nonexclusive License Agreement between BioTime’s subsidiary ES Cell International Pte Ltd (ESI)
1
http://investor.biotimeinc.com/phoenix.zhtml?c=83805&p=irol-newsArticle&id=2038690
